These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11396351)
21. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi Y; Burn P Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736 [No Abstract] [Full Text] [Related]
22. Anti-obesity drugs: use, mechanisms and clinical importance. Adam O; Forth W Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630 [TBL] [Abstract][Full Text] [Related]
23. Pharmageddon on obesity. Rahimnajjad MK; Naeem M; Rahimnajjad NA J Coll Physicians Surg Pak; 2010 Sep; 20(9):635-6. PubMed ID: 20810066 [No Abstract] [Full Text] [Related]
24. The obesity pipeline: current strategies in the development of anti-obesity drugs. Cooke D; Bloom S Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028 [TBL] [Abstract][Full Text] [Related]
25. Obesity: the fat lady sings? Cairns E Drug Discov Today; 2005 Mar; 10(5):305-7. PubMed ID: 15749277 [No Abstract] [Full Text] [Related]
26. [Novel anti-obesity drugs]. Tripp B; Ludvik B Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249 [TBL] [Abstract][Full Text] [Related]
27. [Drug therapy of obesity--from bitter experiences to future possibilities]. Rössner S Lakartidningen; 2000 Apr; 97(14):1726-8. PubMed ID: 10815399 [No Abstract] [Full Text] [Related]
28. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Freemark M Diabetes Care; 2007 Feb; 30(2):395-402. PubMed ID: 17259519 [No Abstract] [Full Text] [Related]
31. The advances on the knowledge base of obesity and future therapeutic directions. Vettor R; Pagano C; Federspil G Eat Weight Disord; 2001 Sep; 6(3 Suppl):40-3. PubMed ID: 11706508 [No Abstract] [Full Text] [Related]
32. Obesity market overview. Farrigan C; Pang K Nat Rev Drug Discov; 2002 Apr; 1(4):257-8. PubMed ID: 12120276 [No Abstract] [Full Text] [Related]
33. [Orlistat. A treatment of limited value for obese persons]. Taeron C Rev Infirm; 2002 Apr; (80):63-4. PubMed ID: 12046132 [No Abstract] [Full Text] [Related]
34. Dietary supplements for weight loss: challenges in evaluation. Allison DB Obes Rev; 2005 May; 6(2):89-92. PubMed ID: 15836458 [No Abstract] [Full Text] [Related]
35. Novel pharmacotherapies for obesity poised to enter market. Jones D Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031 [No Abstract] [Full Text] [Related]
36. The quest for the antifat pill. Stipp D Fortune; 2003 Feb; 147(2):66-7. PubMed ID: 12577860 [No Abstract] [Full Text] [Related]
37. [Obesity--the new challenge]. Hauner H Dtsch Med Wochenschr; 2000 Mar; 125(9):255. PubMed ID: 10742817 [No Abstract] [Full Text] [Related]